| UniProt ID | CEP97_HUMAN | |
|---|---|---|
| UniProt AC | Q8IW35 | |
| Protein Name | Centrosomal protein of 97 kDa | |
| Gene Name | CEP97 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 865 | |
| Subcellular Localization | Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . | |
| Protein Description | Acts as a key negative regulator of ciliogenesis in collaboration with CCP110 by capping the mother centriole thereby preventing cilia formation. Required for recruitment of CCP110 to the centrosome.. | |
| Protein Sequence | MAVARVDAALPPGEGSVVNWSGQGLQKLGPNLPCEADIHTLILDKNQIIKLENLEKCKRLIQLSVANNRLVRMMGVAKLTLLRVLNLPHNSIGCVEGLKELVHLEWLNLAGNNLKAMEQINSCTALQHLDLSDNNISQIGDLSKLVSLKTLLLHGNIITSLRMAPAYLPRSLAILSLAENEIRDLNEISFLASLTELEQLSIMNNPCVMATPSIPGFDYRPYIVSWCLNLRVLDGYVISQKESLKAEWLYSQGKGRAYRPGQHIQLVQYLATVCPLTSTLGLQTAEDAKLEKILSKQRFHQRQLMNQSQNEELSPLVPVETRASLIPEHSSPVQDCQISQESEPVIQVNSWVGINSNDDQLFAVKNNFPASVHTTRYSRNDLHLEDIQTDEDKLNCSLLSSESTFMPVASGLSPLSPTVELRLQGINLGLEDDGVADESVKGLESQVLDKEEEQPLWAANENSVQMMRSEINTEVNEKAGLLPCPEPTIISAILKDDNHSLTFFPESTEQKQSDIKKPENTQPENKETISQATSEKLPMILTQRSVALGQDKVALQKLNDAATKLQACWRGFYARNYNPQAKDVRYEIRLRRMQEHIVCLTDEIRRLRKERDEERIKKFVQEEAFRFLWNQVRSLQVWQQTVDQRLSSWHTDVPPISSTLVPSKHPLFTQSQESSCDQNADWFIASDVAPQEKSLPEFPDSGFHSSLTEQVHSLQHSLDFEKSSTEGSESSIMGNSIDTVRYGKESDLGDVSEEHGEWNKESSNNEQDNSLLEQYLTSVQQLEDADERTNFDTETRDSKLHIACFPVQLDTLSDGASVDESHGISPPLQGEISQTQENSKLNAEVQGQQPECDSTFQLLHVGVTV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 27 | Ubiquitination | WSGQGLQKLGPNLPC CCCCCHHHHCCCCCC | 61.53 | - | |
| 45 | Ubiquitination | IHTLILDKNQIIKLE EEEEEECHHCEEEEC | 47.51 | - | |
| 45 (in isoform 2) | Ubiquitination | - | 47.51 | - | |
| 50 | Acetylation | LDKNQIIKLENLEKC ECHHCEEEECCHHHH | 51.91 | 25953088 | |
| 50 | Ubiquitination | LDKNQIIKLENLEKC ECHHCEEEECCHHHH | 51.91 | - | |
| 64 | Phosphorylation | CKRLIQLSVANNRLV HHHHHHHHHHCCHHH | 11.65 | 24670416 | |
| 144 | Ubiquitination | SQIGDLSKLVSLKTL HHHHHHHHHHCHHHH | 61.27 | - | |
| 241 | Ubiquitination | DGYVISQKESLKAEW CCEEEECHHHHCHHH | 42.34 | - | |
| 241 (in isoform 2) | Ubiquitination | - | 42.34 | - | |
| 245 | Ubiquitination | ISQKESLKAEWLYSQ EECHHHHCHHHHHHC | 54.24 | - | |
| 254 | Ubiquitination | EWLYSQGKGRAYRPG HHHHHCCCCCCCCCC | 37.27 | - | |
| 292 | Ubiquitination | AEDAKLEKILSKQRF HHHHHHHHHHHHHHH | 60.42 | - | |
| 308 | Phosphorylation | QRQLMNQSQNEELSP HHHHHCHHCCCCCCC | 29.93 | 25159151 | |
| 314 | Phosphorylation | QSQNEELSPLVPVET HHCCCCCCCCCCCHH | 21.33 | 25159151 | |
| 321 | Phosphorylation | SPLVPVETRASLIPE CCCCCCHHHHHHCCC | 31.59 | 20068231 | |
| 324 | Phosphorylation | VPVETRASLIPEHSS CCCHHHHHHCCCCCC | 24.44 | 26074081 | |
| 330 | Phosphorylation | ASLIPEHSSPVQDCQ HHHCCCCCCCCCCCC | 34.37 | 26074081 | |
| 331 | Phosphorylation | SLIPEHSSPVQDCQI HHCCCCCCCCCCCCC | 30.88 | 26074081 | |
| 339 | Phosphorylation | PVQDCQISQESEPVI CCCCCCCCCCCCCEE | 11.30 | 26074081 | |
| 342 | Phosphorylation | DCQISQESEPVIQVN CCCCCCCCCCEEEEE | 39.29 | 26074081 | |
| 350 | Phosphorylation | EPVIQVNSWVGINSN CCEEEEEEEEEECCC | 25.04 | 28348404 | |
| 356 | Phosphorylation | NSWVGINSNDDQLFA EEEEEECCCCCCEEE | 39.45 | 28348404 | |
| 371 | Phosphorylation | VKNNFPASVHTTRYS EECCCCCEEEECCCC | 18.05 | 25159151 | |
| 377 | Phosphorylation | ASVHTTRYSRNDLHL CEEEECCCCCCCCCH | 15.19 | 28555341 | |
| 378 | Phosphorylation | SVHTTRYSRNDLHLE EEEECCCCCCCCCHH | 22.71 | 29449344 | |
| 389 | Phosphorylation | LHLEDIQTDEDKLNC CCHHHHCCCHHHHCC | 41.51 | 27080861 | |
| 397 | Phosphorylation | DEDKLNCSLLSSEST CHHHHCCCCCCCCCC | 31.13 | 22199227 | |
| 400 | Phosphorylation | KLNCSLLSSESTFMP HHCCCCCCCCCCCCC | 37.03 | 22199227 | |
| 401 | Phosphorylation | LNCSLLSSESTFMPV HCCCCCCCCCCCCCC | 35.22 | 22199227 | |
| 403 | Phosphorylation | CSLLSSESTFMPVAS CCCCCCCCCCCCCCC | 28.97 | 22199227 | |
| 404 | Phosphorylation | SLLSSESTFMPVASG CCCCCCCCCCCCCCC | 21.65 | 22199227 | |
| 410 | Phosphorylation | STFMPVASGLSPLSP CCCCCCCCCCCCCCC | 40.27 | 28450419 | |
| 413 | Phosphorylation | MPVASGLSPLSPTVE CCCCCCCCCCCCCEE | 27.59 | 23898821 | |
| 416 | Phosphorylation | ASGLSPLSPTVELRL CCCCCCCCCCEEEEE | 23.16 | 25159151 | |
| 418 | Phosphorylation | GLSPLSPTVELRLQG CCCCCCCCEEEEECC | 24.20 | 28102081 | |
| 439 | Phosphorylation | DDGVADESVKGLESQ CCCCCCHHHCCHHHH | 29.67 | 30576142 | |
| 445 | Phosphorylation | ESVKGLESQVLDKEE HHHCCHHHHCCCCCC | 30.54 | 21815630 | |
| 478 | Ubiquitination | INTEVNEKAGLLPCP HHHHHHHHCCCCCCC | 42.42 | - | |
| 488 | Phosphorylation | LLPCPEPTIISAILK CCCCCCCCEEEEEEC | 29.31 | 27251275 | |
| 491 | Phosphorylation | CPEPTIISAILKDDN CCCCCEEEEEECCCC | 12.85 | 24719451 | |
| 495 | Ubiquitination | TIISAILKDDNHSLT CEEEEEECCCCCCCE | 57.85 | - | |
| 500 | Phosphorylation | ILKDDNHSLTFFPES EECCCCCCCEECCCC | 35.05 | 23401153 | |
| 502 | Phosphorylation | KDDNHSLTFFPESTE CCCCCCCEECCCCCC | 26.67 | 29255136 | |
| 507 | Phosphorylation | SLTFFPESTEQKQSD CCEECCCCCCCCHHH | 37.17 | 23403867 | |
| 511 | Ubiquitination | FPESTEQKQSDIKKP CCCCCCCCHHHCCCC | 45.60 | - | |
| 530 | Phosphorylation | PENKETISQATSEKL CCCHHHHHHHHHCCC | 22.60 | - | |
| 534 | Phosphorylation | ETISQATSEKLPMIL HHHHHHHHCCCCEEH | 35.43 | 25627689 | |
| 542 | Phosphorylation | EKLPMILTQRSVALG CCCCEEHHHHHHHCC | 15.83 | 17525332 | |
| 545 | Phosphorylation | PMILTQRSVALGQDK CEEHHHHHHHCCCCH | 11.26 | 25159151 | |
| 552 | Acetylation | SVALGQDKVALQKLN HHHCCCCHHHHHHHH | 22.86 | 23236377 | |
| 552 | Ubiquitination | SVALGQDKVALQKLN HHHCCCCHHHHHHHH | 22.86 | - | |
| 552 (in isoform 2) | Ubiquitination | - | 22.86 | - | |
| 557 | Ubiquitination | QDKVALQKLNDAATK CCHHHHHHHHHHHHH | 50.54 | - | |
| 557 (in isoform 2) | Ubiquitination | - | 50.54 | - | |
| 564 | Acetylation | KLNDAATKLQACWRG HHHHHHHHHHHHHHH | 33.60 | 23236377 | |
| 564 | Ubiquitination | KLNDAATKLQACWRG HHHHHHHHHHHHHHH | 33.60 | - | |
| 564 (in isoform 2) | Ubiquitination | - | 33.60 | - | |
| 582 | Ubiquitination | RNYNPQAKDVRYEIR CCCCCCCCCHHHHHH | 52.05 | - | |
| 582 (in isoform 2) | Ubiquitination | - | 52.05 | - | |
| 617 (in isoform 2) | Ubiquitination | - | 46.51 | - | |
| 618 | Ubiquitination | RDEERIKKFVQEEAF CCHHHHHHHHHHHHH | 48.69 | - | |
| 618 (in isoform 2) | Ubiquitination | - | 48.69 | - | |
| 648 | Phosphorylation | TVDQRLSSWHTDVPP HHHHHHHHHCCCCCC | 27.71 | 28555341 | |
| 651 | Phosphorylation | QRLSSWHTDVPPISS HHHHHHCCCCCCCCC | 32.22 | 28555341 | |
| 657 | Phosphorylation | HTDVPPISSTLVPSK CCCCCCCCCCCCCCC | 24.04 | 28555341 | |
| 669 | Phosphorylation | PSKHPLFTQSQESSC CCCCCCCCCCCCCCC | 34.69 | 28857561 | |
| 671 | Phosphorylation | KHPLFTQSQESSCDQ CCCCCCCCCCCCCCC | 32.62 | 28857561 | |
| 674 | Phosphorylation | LFTQSQESSCDQNAD CCCCCCCCCCCCCCC | 28.73 | 28857561 | |
| 675 | Phosphorylation | FTQSQESSCDQNADW CCCCCCCCCCCCCCE | 22.44 | 24719451 | |
| 694 | Phosphorylation | DVAPQEKSLPEFPDS CCCCCCCCCCCCCCC | 48.69 | - | |
| 708 | Phosphorylation | SGFHSSLTEQVHSLQ CCCCHHHHHHHHHHH | 26.73 | - | |
| 717 | Phosphorylation | QVHSLQHSLDFEKSS HHHHHHHHCCCCCCC | 19.37 | 27251275 | |
| 723 | Phosphorylation | HSLDFEKSSTEGSES HHCCCCCCCCCCCCC | 34.98 | 25159151 | |
| 724 | Phosphorylation | SLDFEKSSTEGSESS HCCCCCCCCCCCCCH | 41.36 | 25159151 | |
| 725 | Phosphorylation | LDFEKSSTEGSESSI CCCCCCCCCCCCCHH | 52.00 | 28985074 | |
| 728 | Phosphorylation | EKSSTEGSESSIMGN CCCCCCCCCCHHCCC | 28.24 | 26471730 | |
| 730 | Phosphorylation | SSTEGSESSIMGNSI CCCCCCCCHHCCCCC | 27.19 | 27251275 | |
| 731 | Phosphorylation | STEGSESSIMGNSID CCCCCCCHHCCCCCC | 16.73 | 27251275 | |
| 733 | Sulfoxidation | EGSESSIMGNSIDTV CCCCCHHCCCCCCEE | 4.49 | 21406390 | |
| 736 | Phosphorylation | ESSIMGNSIDTVRYG CCHHCCCCCCEEECC | 18.99 | 21815630 | |
| 739 | Phosphorylation | IMGNSIDTVRYGKES HCCCCCCEEECCCCC | 12.76 | 27251275 | |
| 742 | Phosphorylation | NSIDTVRYGKESDLG CCCCEEECCCCCCCC | 28.36 | 30576142 | |
| 744 | Ubiquitination | IDTVRYGKESDLGDV CCEEECCCCCCCCCC | 45.14 | - | |
| 746 | Phosphorylation | TVRYGKESDLGDVSE EEECCCCCCCCCCCH | 41.44 | 30576142 | |
| 752 | Phosphorylation | ESDLGDVSEEHGEWN CCCCCCCCHHHCCCC | 41.84 | 30576142 | |
| 762 | Phosphorylation | HGEWNKESSNNEQDN HCCCCCCCCCCHHHH | 39.72 | 29116813 | |
| 763 | Phosphorylation | GEWNKESSNNEQDNS CCCCCCCCCCHHHHH | 44.78 | 21712546 | |
| 770 | Phosphorylation | SNNEQDNSLLEQYLT CCCHHHHHHHHHHHH | 42.49 | 21712546 | |
| 775 | Phosphorylation | DNSLLEQYLTSVQQL HHHHHHHHHHHHHHH | 11.54 | 29116813 | |
| 777 | Phosphorylation | SLLEQYLTSVQQLED HHHHHHHHHHHHHHC | 23.17 | 20873877 | |
| 778 | Phosphorylation | LLEQYLTSVQQLEDA HHHHHHHHHHHHHCC | 18.48 | 20873877 | |
| 793 | Phosphorylation | DERTNFDTETRDSKL CHHCCCCCCCCCCCE | 34.81 | 28348404 | |
| 795 | Phosphorylation | RTNFDTETRDSKLHI HCCCCCCCCCCCEEE | 41.70 | 26074081 | |
| 798 | Phosphorylation | FDTETRDSKLHIACF CCCCCCCCCEEEEEE | 33.55 | 26074081 | |
| 799 | Ubiquitination | DTETRDSKLHIACFP CCCCCCCCEEEEEEE | 48.66 | - | |
| 811 | Phosphorylation | CFPVQLDTLSDGASV EEEEEECCCCCCCCC | 36.43 | 28122231 | |
| 813 | Phosphorylation | PVQLDTLSDGASVDE EEEECCCCCCCCCCH | 35.77 | 28348404 | |
| 817 | Phosphorylation | DTLSDGASVDESHGI CCCCCCCCCCHHCCC | 35.31 | 28348404 | |
| 821 | Phosphorylation | DGASVDESHGISPPL CCCCCCHHCCCCCCC | 23.66 | 28348404 | |
| 825 | Phosphorylation | VDESHGISPPLQGEI CCHHCCCCCCCCCCC | 25.67 | 25159151 | |
| 833 | Phosphorylation | PPLQGEISQTQENSK CCCCCCCCCCHHHHH | 23.91 | 20873877 | |
| 835 | Phosphorylation | LQGEISQTQENSKLN CCCCCCCCHHHHHHC | 30.93 | 20873877 | |
| 839 | Phosphorylation | ISQTQENSKLNAEVQ CCCCHHHHHHCHHHC | 37.45 | 26552605 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CEP97_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CEP97_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-308, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-763; SER-770; THR-811;SER-813 AND SER-817, AND MASS SPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-542, AND MASSSPECTROMETRY. | |